redical-logo

THE RADICAL REMISSION PROJECT PARTNERS WITH ATRECA TO STUDY YOUR IMMUNE SYSTEM

Have you been diagnosed with cancer?
Is your disease stable, responding or in remission?

Please consider participating in our observational research aimed at studying how the human immune system fights cancer. The immune system protects us by recognizing and eliminating threats, but cancer cells are skilled at evading the body's natural immune response. Fortunately, the human immune system is resilient and constantly adapting to better locate and attack threats such as cancer cells. With this research, we hope to advance our understanding of how the immune system fights cancer and enable new treatments along the way.

Participate in our study
steps

OUR PURPOSE

This research aims to study the effective anti-tumor immune responses of patients like you. Your blood can help us understand how the immune system adapts to fight cancer.

steps

STEPS INVOLVED

The study involves a phone interview with the research professionals at Atreca to assess whether the study is a good match for you. If you qualify, we will send a technician to you to collect a blood sample.

steps

PARTICIPATE

Atreca's clinical research professionals are here to talk to you. If you are interested in participating in our research study or would simply like to find out more, please fill out the screening questionnaire below.

Screening Questionnaire

If you would like to find out more about our study and whether you are eligible, please consider the following statements and check the box next to the statement that best applies to you:

Question 1 of 10

Question 2 of 10

Question 3 of 10

Question 4 of 10

Question 5 of 10

Question 6 of 10

Question 7 of 10

Question 8 of 10

Question 9 of 10

Question 10 of 10

You may be eligible to participate in our study. Please complete the form below and one of our clinical research professionals will call you to discuss next steps.

Thank you for your responses and your interest in our study! You are not currently eligible for this study, but you may be eligible for other studies like it in the future. If you would like to be contacted about future studies, please fill out the form below. We thank you again for your time and consideration in contributing to our research!

ABOUT ATRECA

Atreca, Inc. is a biotechnology company founded on the invention of a novel technology by Stanford scientists Bill Robinson, MD, PhD and Yann Chong Tan, PhD. Atreca has developed this technology to help identify and analyze proteins called antibodies that are made by the immune system. Some anti-tumor antibodies will stick to the surface of tumor cells and alert the rest of your immune system to attack those harmful cells. Atreca’s goal is to identify those well-adapted antibodies so that we can both advance our knowledge of cancer as a disease, and seek new treatments for future patients.